Overview
"Retrospectively collecting clinical data from post-PVA (Percutaneous Vertebroplasty) patients, recording incidences of secondary vertebral fractures, and conducting statistical analysis to create a risk prediction model for recurrent fractures."
Eligibility
Inclusion Criteria:
- Meets the diagnostic criteria for primary osteoporosis as per the Osteoporosis Diagnosis and Treatment Guidelines (2022);
- No history of high-energy trauma;
- Patient complains of pain in the lumbar region, confirmed by MRI showing a newly developed vertebral fracture from T5 to L5 (i.e., MRI shows low signal on T1 and high or slightly high signal on T2);
- Has undergone Percutaneous Vertebroplasty (PVA) treatment.
Exclusion Criteria:
- Incomplete imaging or medical record data;
- History of spinal surgeries other than PVA;
- Pre-existing symptoms of spinal cord compression or nerve root injury;
- Patients undergoing PVA treatment due to conditions such as tumors, vascular malformations, infections, or symptomatic Schmorl's nodes;
- Chronic conditions like Kummell's disease or non-union of old fractures;
- Concurrent vertebral burst fractures;
- Diagnosis of central nervous system diseases such as dementia or stroke before or during the follow-up period post-PVA procedure;
- History of violent trauma after PVA procedure.